Absci and amd announce collaboration and strategic investment to accelerate the future of ai drug discovery

$20 million equity investment from amd strengthens absci's leadership in ai drug discovery and further expands biopharma adoption of amd instinct accelerators and rocm software $20 million equity investment from amd strengthens absci's leadership in ai drug discovery and further expands biopharma adoption of amd instinct accelerators and rocm software
ABSI Ratings Summary
ABSI Quant Ranking